Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemia.

The combined endpoint of re-development of severe anemia and survival at 28 days following admission also favored the arm receiving 30 ml/kg, but the fact that this was designed as a pilot safety trial meant that it was not powered to detect differences of this magnitude and did not reach statistical significance ( P = 0.25).

also in 111,027 other papers